Scott Schoenhaus
Stock Analyst at KeyBanc
(0.53)
# 4,364
Out of 5,116 analysts
208
Total ratings
42%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Reiterated: Hold | n/a | $79.40 | - | 2 | Nov 6, 2026 | |
| ABSI Absci | Reiterated: Buy | $9 → $20 | $10.17 | +96.66% | 7 | Oct 16, 2026 | |
| CERT Certara | Reiterated: Buy | $8 → $12 | $12.05 | -0.41% | 10 | Oct 16, 2026 | |
| HNGE Hinge Health | Reiterated: Buy | $125 → $140 | $115.76 | +20.94% | 6 | Oct 16, 2026 | |
| SDGR Schrödinger | Reiterated: Buy | $20 → $32 | $29.82 | +7.31% | 13 | Oct 16, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $30 → $35 | $28.35 | +23.46% | 3 | Oct 16, 2026 | |
| IDXX IDEXX Laboratories | Initiated Coverage: Hold | n/a | $676.04 | - | 1 | Oct 12, 2026 | |
| OMCL Omnicell | Reiterated: Buy | $65 | $37.34 | +74.08% | 17 | Aug 24, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $125 | $103.63 | +20.62% | 17 | Aug 18, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $5 | $2.37 | +110.97% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $25.74 | +16.55% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $35 | $34.84 | +0.46% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $20.18 | - | 10 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $32.51 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $12 | $12.62 | -4.91% | 14 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.77 | - | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.86 | - | 11 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.51 | - | 10 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.46 | - | 7 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $303.73 | - | 17 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $11.88 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $13.77 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $3.52 | n/a | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.80 | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $175 → $250 | $271.83 | n/a | 3 | Apr 16, 2021 |
Zoetis
Nov 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $79.40
Upside: -
Absci
Oct 16, 2026
Reiterated: Buy
Price Target: $9 → $20
Current: $10.17
Upside: +96.66%
Certara
Oct 16, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $12.05
Upside: -0.41%
Hinge Health
Oct 16, 2026
Reiterated: Buy
Price Target: $125 → $140
Current: $115.76
Upside: +20.94%
Schrödinger
Oct 16, 2026
Reiterated: Buy
Price Target: $20 → $32
Current: $29.82
Upside: +7.31%
Waystar Holding
Oct 16, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $28.35
Upside: +23.46%
IDEXX Laboratories
Oct 12, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $676.04
Upside: -
Omnicell
Aug 24, 2026
Reiterated: Buy
Price Target: $65
Current: $37.34
Upside: +74.08%
HealthEquity
Aug 18, 2026
Reiterated: Buy
Price Target: $125
Current: $103.63
Upside: +20.62%
LifeMD
Aug 7, 2026
Reiterated: Buy
Price Target: $5
Current: $2.37
Upside: +110.97%
Aug 6, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $25.74
Upside: +16.55%
Jul 13, 2026
Reiterated: Buy
Price Target: $28 → $35
Current: $34.84
Upside: +0.46%
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $20.18
Upside: -
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.51
Upside: -
Apr 13, 2026
Rated: Buy
Price Target: $32 → $12
Current: $12.62
Upside: -4.91%
Feb 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.77
Upside: -
Feb 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.86
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $3.51
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $1.46
Upside: -
Dec 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $303.73
Upside: -
Apr 16, 2025
Reiterated: Buy
Price Target: $4 → $5
Current: $11.88
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $13.77
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $12 → $10
Current: $3.52
Upside: n/a
Sep 15, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $4.80
Upside: n/a
Apr 16, 2021
Upgraded: Buy
Price Target: $175 → $250
Current: $271.83
Upside: n/a